Nothing Special   »   [go: up one dir, main page]

Ivanova et al., 2017 - Google Patents

The Content Analysis of ALDH^ sup+^ and SORE6^ sup+^ Populations of Cells in Cellular Lines of Thriple Negative Breast Cancer

Ivanova et al., 2017

Document ID
2034927812126714470
Author
Ivanova A
Kravchenko D
Lezhnin Y
Chumakov S
Frolova E
Publication year
Publication venue
Journal of Pharmaceutical Sciences and Research

External Links

Snippet

Keywords: cancer stem cells, thriple negative breast cancer, glioblastoma, aldehyde dehydrogenase, reporter of SORE6. In neuronal and haematopoietic stem cells ALDH1 transfers retinal to retinoic acid, which through activation of its own nuclear receptors, serves …
Continue reading at search.proquest.com (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57415Specifically defined cancers of breast
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/574Immunoassay; Biospecific binding assay for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Hybridisation probes

Similar Documents

Publication Publication Date Title
Gossett et al. Hydrodynamic stretching of single cells for large population mechanical phenotyping
Posadas et al. FYN is overexpressed in human prostate cancer
Vermeulen et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity
Duru et al. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells
Zantek et al. MCF-10A-NeoST: a new cell system for studying cell-ECM and cell-cell interactions in breast cancer
Sonnenblick et al. Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis
CN102812130A (en) Recurrent Gene Fusions In Prostate Cancer
Yamamoto et al. Metastasis from the tumor interior and necrotic core formation are regulated by breast cancer-derived angiopoietin-like 7
Carlsson et al. Paired high-content analysis of prostate cancer cells in bone marrow and blood characterizes increased androgen receptor expression in tumor cell clusters
Li et al. Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes Tenascin-C as a stromal biomarker for colorectal cancer metastasis
Bagatur et al. Tissue transglutaminase expression is necessary for adhesion, metastatic potential and cancer stemness of renal cell carcinoma
EP2823035A1 (en) Adhesion signatures
Li et al. Expression and clinical implication of S100A12 in gastric carcinoma
Felipe-Abrio et al. Loss of MYBBP1A induces cancer stem cell activity in renal cancer
Lee et al. Activated PyK2 and its Associated molecules Transduce Cellular Signaling from the cancerous milieu for Cancer Metastasis
Lamarca et al. Urine telomerase for diagnosis and surveillance of bladder cancer
CN103698536A (en) Oncoprotein P185 detection kit
Kaur et al. Complex tumor spheroids, a tissue-mimicking tumor model, for drug discovery and precision medicine
Li et al. Telomerase activity in preleukemia and acute myelogenous leukemia
Kim et al. Expression of spermine oxidase is associated with colorectal carcinogenesis and prognosis of patients
Roelofs et al. Aberrant apobec3b expression in breast cancer is linked to proliferation and cell cycle phase
Eturi et al. Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma
Ivanova et al. The Content Analysis of ALDH^ sup+^ and SORE6^ sup+^ Populations of Cells in Cellular Lines of Thriple Negative Breast Cancer
McKeever et al. Patterns of antigenic expression of human glioma cells.
CN102053150B (en) Human osteosarcoma stem cell related antigen marker and application thereof